FDA issues Class I recall label to Insulet’s Omnipod Android app over incorrect bolus calculations
The FDA has handed down a Class I recall label, the agency’s most serious, to a now-corrected software issue that could have resulted in delivering ten times the desired insulin dose from Insulet’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback